22q11 Deletion Syndrome
|
0.390 |
Biomarker
|
disease |
BEFREE |
Thus, human TBX1 is a candidate for some of the features seen in the 22q11 deletion syndrome.
|
9268629 |
1997 |
22q11 Deletion Syndrome
|
0.390 |
Biomarker
|
disease |
BEFREE |
A likely role for Tbx1 haploinsufficiency in psychiatric disease is further suggested by the identification of a family in which the phenotypic features of 22q11DS, including psychiatric disorders, segregate with an inactivating mutation of TBX1.
|
16684884 |
2006 |
22q11 Deletion Syndrome
|
0.390 |
Biomarker
|
disease |
BEFREE |
22q11 deletion syndrome (22qDS), also known as DiGeorge or velocardiofacial syndrome (DGS/VCFS), is a relatively common genetic anomaly that results in malformations of the heart, face and limbs.
|
12175881 |
2002 |
22q11 Deletion Syndrome
|
0.390 |
GermlineCausalMutation
|
disease |
ORPHANET |
Role of TBX1 in human del22q11.2 syndrome.
|
14585638 |
2003 |
22q11 Deletion Syndrome
|
0.390 |
Biomarker
|
disease |
BEFREE |
A typical developmental disorder of the pharyngeal apparatus is the 22q11 deletion syndrome (22q11DS), for which Tbx1 is responsible.
|
21177346 |
2011 |
22q11 Deletion Syndrome
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Twenty children and young adults (age range 5 to 33 years, 12 females and eight males) with genetically confirmed 22q11 deletion syndrome (CATCH 22: Cardiac anomaly, Anomalous face, Thymus hypoplasia/aplasia, Cleft palate, and Hypocalcaemia), recruited from a large ongoing study, were given comprehensive assessments with a view to determining the pattern of neuropsychiatric and neuropsychological deficits thought to be part of the syndrome in many cases.
|
11811651 |
2002 |
22q11 Deletion Syndrome
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
A study has also shown that phenotypic features of 22q11 deletion syndrome (22q11DS) were segregated with an inactivating mutation of TBX1 in one family, suggesting that the TBX1 gene plays a role in the pathogenesis of some psychiatric disorders.
|
17850965 |
2007 |
22q11 Deletion Syndrome
|
0.390 |
ChromosomalRearrangement
|
disease |
ORPHANET |
|
|
|
22q11 Deletion Syndrome
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the coding regions of TBX1 gene have been associated to 22q11 deletion syndrome with cardiac defects and isolated CHD cases, including ventricular septal defect (VSD).
|
22801995 |
2012 |
22q11 Deletion Syndrome
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
This hypomorphic Tbx1 allele per se results in defects resembling 22q11DS but with a low penetrance of hallmark craniofacial malformations, unless chordin is mutant.
|
19247433 |
2009 |
22q11 Deletion Syndrome
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Based on these results we conclude that TBX1 variation does not make a strong contribution to the genetic etiology of nonsyndromic forms of psychiatric disorders commonly seen in patients with 22q11DS.
|
17622328 |
2007 |
22q11 partial monosomy syndrome
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Chromosome 22q11 deletion syndrome (CATCH 22): neuropsychiatric and neuropsychological aspects.
|
11811651 |
2002 |
22q11 partial monosomy syndrome
|
0.310 |
ChromosomalRearrangement
|
disease |
ORPHANET |
|
|
|
22q11 partial monosomy syndrome
|
0.310 |
GermlineCausalMutation
|
disease |
ORPHANET |
Role of TBX1 in human del22q11.2 syndrome.
|
14585638 |
2003 |
3-Methylglutaconic aciduria type 2
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
This abnormality involves the deletion of the bases TGA starting at cDNA nucleotide 891 (c891_893delTGA), resulting in the absence of glutamic acid at codon 202 from a highly conserved area of the tafazzin protein, consistent with the diagnosis of Barth syndrome.
|
20981509 |
2010 |
3C syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
This observation confirms the previous finding of cerebellar anomalies in Shprintzen syndrome, and suggests an overlap between the VCFS and 3C syndrome.
|
8870617 |
1996 |
Abnormal behavior
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
We have previously shown that Tbx1 heterozygous mice have reduced prepulse inhibition, a behavioral abnormality that is associated with 22q11.2DS and nonsyndromic schizophrenia.
|
27005988 |
2017 |
Abnormal behavior
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
The identification of candidate genes for heart anomalies, mental illness, and other clinical phenotypes has been reported in the past year with a focus on TBX1 for cardiac and craniofacial phenotypes and COMT and PRODH for psychiatric disorders.
|
16282778 |
2005 |
Abnormal behavior
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
A study has also shown that phenotypic features of 22q11 deletion syndrome (22q11DS) were segregated with an inactivating mutation of TBX1 in one family, suggesting that the TBX1 gene plays a role in the pathogenesis of some psychiatric disorders.
|
17850965 |
2007 |
Abnormal behavior
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
Although Tbx1 has been shown to be responsible for many physical defects associated with 22q11.2 haploinsufficiency, Tbx1 heterozygous mice did not display these behavioral abnormalities.
|
16365290 |
2005 |
Abnormal behavior
|
0.070 |
GeneticVariation
|
phenotype |
BEFREE |
Velocardiofacial (VCFS; 22q11.2 deletion) syndrome is a genetic disorder that results from a hemizygous deletion of the q11.2 region on chromosome 22, and is associated with greatly increased risk for psychiatric disorders, including autism spectrum disorder (ASD) and schizophrenia.
|
25325218 |
2014 |
Abnormal behavior
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
A likely role for Tbx1 haploinsufficiency in psychiatric disease is further suggested by the identification of a family in which the phenotypic features of 22q11DS, including psychiatric disorders, segregate with an inactivating mutation of TBX1.
|
16684884 |
2006 |
Abnormal behavior
|
0.070 |
GeneticVariation
|
phenotype |
BEFREE |
Based on these results we conclude that TBX1 variation does not make a strong contribution to the genetic etiology of nonsyndromic forms of psychiatric disorders commonly seen in patients with 22q11DS.
|
17622328 |
2007 |
Abnormal lung lobation
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormal nasal morphology
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|